Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Th1, Type 1 T helper"'
Autor:
Shilpa Bhuaptrai Shah
Publikováno v:
Endocrine and Metabolic Science, Vol 5, Iss , Pp 100110- (2021)
Severely ill COVID–19 (Corona Virus Disease of 2019) patients have a hyperinflammatory condition with a high concentration of pro-inflammatory cytokines termed the cytokine storm. This milieu is reported to cause acute lung injury, oxygen deprivati
Externí odkaz:
https://doaj.org/article/90943e3a2f7b4cf3812a915b91ac5daf
Publikováno v:
Advanced Drug Delivery Reviews
Graphical abstract
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76811ce2af0ea0f7b3342230007c3c01
https://doi.org/10.1016/j.addr.2021.03.018
https://doi.org/10.1016/j.addr.2021.03.018
Publikováno v:
Advanced Drug Delivery Reviews
mRNA vaccines have evolved from being a mere curiosity to emerging as COVID-19 vaccine front-runners. Recent advancements in the field of RNA technology, vaccinology, and nanotechnology have generated interest in delivering safe and effective mRNA th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0f88a1e945504ba8b4af825e8da083
https://doi.org/10.1016/j.addr.2020.12.014
https://doi.org/10.1016/j.addr.2020.12.014
Autor:
Moiz Bakhiet, Sebastien Taurin
Publikováno v:
Cytokine & Growth Factor Reviews
Graphical abstract
Highlights • A year since the first report of the SARS-CoV-2, over 57 million cases have been diagnosed, and over 1.37 million have died worldwide. • An uncontrolled inflammatory response linked to a cytokine storm has bee
Highlights • A year since the first report of the SARS-CoV-2, over 57 million cases have been diagnosed, and over 1.37 million have died worldwide. • An uncontrolled inflammatory response linked to a cytokine storm has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d90c5c14dd654c743b9b7beb4efc00a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nobutaka Tsutsu, Shiori Kondo, Keiichiro Mine, Kanako Hirakawa, Yasunobu Yoshikai, Keizo Anzai, Fumiko Kojima, Seiho Nagafuchi, Masae Minami, Akira Okada, Yumi Hibio, Hironori Kurisaki, Shuji Fujimoto, Yasushi Yokogawa
Publikováno v:
EBioMedicine
EBioMedicine, Vol 23, Iss C, Pp 46-51 (2017)
EBioMedicine, Vol 23, Iss C, Pp 46-51 (2017)
Objective Type 1 diabetes (T1D) is known to be caused by Th1 cell-dependent autoimmunity. Recently, we reported that TYK2 promoter variant serves as a putative virus-induced diabetes susceptibility gene associated with deteriorated interferon-depende
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dba89f6bbfb05ec31dc78631b7d0c2a1
http://europepmc.org/articles/PMC5605380
http://europepmc.org/articles/PMC5605380
Autor:
Koshak A; Research Cluster Biodiversity and Medicines, UCL School of Pharmacy, University College London, London, UK.; Department of Natural Products & Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Koshak E; Allergy and Clinical Immunology Division, Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia., Heinrich M; Research Cluster Biodiversity and Medicines, UCL School of Pharmacy, University College London, London, UK.
Publikováno v:
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2017 Dec; Vol. 25 (8), pp. 1130-1136. Date of Electronic Publication: 2017 Jul 11.
Autor:
Werter IM; Department of Medical Oncology; VU University Medical Center ; Amsterdam, The Netherlands., Schneiders FL; Department of Medical Oncology; VU University Medical Center ; Amsterdam, The Netherlands., Scotet E; Institut National de la Santé et de la Recherche Médicale; UMR892; Center de Recherche en Cancérologie Nantes-Angers ; Nantes Cedex, France., Verheul HM; Department of Medical Oncology; VU University Medical Center ; Amsterdam, The Netherlands., de Gruijl TD; Department of Medical Oncology; VU University Medical Center ; Amsterdam, The Netherlands., van der Vliet HJ; Department of Medical Oncology; VU University Medical Center ; Amsterdam, The Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2014 Dec 08; Vol. 3 (9), pp. e955343. Date of Electronic Publication: 2014 Dec 08 (Print Publication: 2014).